 Connection
Hitoshi Irabu to Adolescent
This is a "connection" page, showing publications Hitoshi Irabu has written about Adolescent.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.284 |
|
|
|
-
Irabu H, Ohara A, Nakamura A, Narazaki H, Hayashi Y, Yamasaki Y, Iwata N, Ohshima S, Nishiyama S, Nakagishi Y, Fukuhara D, Ishida H, Goto M, Hashimoto K, Yasuoka R, Nozawa T, Miyamae T, Umebayashi H, Mori M, Shimizu M. Validation of the 2019 EULAR/ACR classification criteria and clinical characteristics of childhood-onset Japanese patients with systemic lupus erythematosus. Mod Rheumatol. 2026 Mar 05; 36(2):239-245.
Score: 0.060
-
Irabu H, Shimizu M, Kaneko S, Inoue N, Mizuta M, Ohta K, Yachie A. Clinical Significance of Serum Galactose-Deficient IgA1 Level in Children with IgA Nephropathy. J Immunol Res. 2020; 2020:4284379.
Score: 0.040
-
Irabu H, Shimizu M, Kaneko S, Inoue N, Mizuta M, Tasaki Y, Ohta K, Yachie A, Wada T. Apoptosis inhibitor of macrophage as a biomarker for disease activity in Japanese children with IgA nephropathy and Henoch-Schönlein purpura nephritis. Pediatr Res. 2021 02; 89(3):667-672.
Score: 0.040
-
Kaneko S, Mizuta M, Hatano M, Shimbo A, Irabu H, Yatabe R, Akamine K, Sugita Y, Hashimoto K, Yamasaki Y, Nakagishi Y, Mori M, Takagi M, Shimizu M. Distinct cytokine signature in juvenile dermatomyositis: linking myositis-specific antibodies and clinical manifestations. Cytokine. 2026 Jan; 197:157070.
Score: 0.015
-
Shimbo A, Kaneko S, Irabu H, Akutsu Y, Hayashi Y, Mouri M, Yamazaki S, Mori M, Shimizu M. Efficacy of hydroxychloroquine treatment for the skin manifestations of juvenile dermatomyositis. Mod Rheumatol Case Rep. 2025 07 25; 9(2).
Score: 0.014
-
Shmizu M, Kaneko S, Shimbo A, Hatano M, Miyaoka F, Irabu H, Akutsu Y, Hayashi Y, Akamine K, Mori M. Anifrolumab for refractory cutaneous lupus lesions in pediatric systemic lupus erythematosus. Lupus. 2025 Apr; 34(5):533-536.
Score: 0.014
-
Eguchi G, Murakoshi M, Miyaoka F, Shimbo A, Irabu H, Kanamori T, Udagawa T, Morio T, Shimizu M. Acute tubulointerstitial nephritis following coronavirus disease 2019 mRNA vaccination: a pediatric case report. CEN Case Rep. 2025 Apr; 14(2):261-265.
Score: 0.014
-
Kaneko S, Shimbo A, Irabu H, Mizuta M, Nakagishi Y, Iwata N, Yokoyama K, Yasumura J, Akamine K, Ueno K, Fujita S, Watanabe K, Watanabe S, Nishikawa H, Fujimura J, Mori M, Shimizu M. Serum interleukin-18 levels can improve the diagnostic performance of the PRINTO and ILAR criteria for systemic juvenile idiopathic arthritis. Cytokine. 2024 10; 182:156719.
Score: 0.013
-
Kaneko S, Shimbo A, Irabu H, Hatano M, Takasawa K, Kamiya T, Akamine K, Tanaka T, Minato T, Ono M, Yokoyama K, Arisaka A, Yasumi T, Ueno K, Fujita S, Tanaka Y, Hayashi D, Nishikawa H, Fujita Y, Yuza Y, Mori M, Morio T, Shimizu M. Pathogenic role and diagnostic utility of interferon-a in histiocytic necrotizing lymphadenitis. Clin Immunol. 2024 Sep; 266:110324.
Score: 0.013
-
Kaneko S, Shimizu M, Shimbo A, Irabu H, Yokoyama K, Furuno K, Tanaka T, Ueno K, Fujita S, Iwata N, Fujimura J, Akamine K, Mizuta M, Nakagishi Y, Minato T, Watanabe K, Kobayashi A, Endo T, Tabata K, Mori M, Morio T. Clinical significance of serum cytokine profiles for differentiating between Kawasaki disease and its mimickers. Cytokine. 2023 09; 169:156280.
Score: 0.012
-
Mizuta M, Shimizu M, Irabu H, Usami M, Inoue N, Nakagishi Y, Wada T, Yachie A. Comparison of serum cytokine profiles in macrophage activation syndrome complicating different background rheumatic diseases in children. Rheumatology (Oxford). 2021 01 05; 60(1):231-238.
Score: 0.010
-
Yokoyama T, Takemura Y, Irabu H, Taniguchi C, Jinkawa A, Yamamiya M, Obata M, Miyashita K, Inoue M, Sakazume S, Ohta K. Clinical Characteristics of Pediatric Pyelonephritis Without Pyuria or Bacteriuria. Pediatr Infect Dis J. 2020 05; 39(5):385-388.
Score: 0.010
-
Usami M, Shimizu M, Mizuta M, Inoue N, Irabu H, Sakumura N, Nakagishi Y, Yachie A. Extensive serum biomarker analysis in patients with macrophage activation syndrome associated with systemic lupus erythematosus. Clin Immunol. 2019 11; 208:108255.
Score: 0.010
-
Fujita S, Nishida K, Irabu H, Nakagawa R, Futatani T, Igarashi N, Usuda K, Nagata Y, Ohno S, Horie M, Hatasaki K. Catecholaminergic polymorphic ventricular tachycardia managed as orthostatic dysregulation and epilepsy in 11- and 15-year-old sisters. Pediatr Int. 2018 Nov; 60(11):998-1001.
Score: 0.009
-
Shimizu M, Inoue N, Kuroda M, Irabu H, Takakura M, Kaneda H, Sugimoto N, Ohta K, Yachie A. Serum ferritin as an indicator of the development of encephalopathy in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome. Clin Exp Nephrol. 2017 Dec; 21(6):1083-1087.
Score: 0.008
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|